Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Natural killer cell subsets differentially reject embryonic stem cells based on licensing.

Perez-Cunningham J, Ames E, Smith RC, Peter AK, Naidu R, Nolta JA, Murphy WJ.

Transplantation. 2014 May 27;97(10):992-8. doi: 10.1097/TP.0000000000000063.

PMID:
24704665
[PubMed - indexed for MEDLINE]
2.

NK cells rapidly reject allogeneic bone marrow in the spleen through a perforin- and Ly49D-dependent, but NKG2D-independent mechanism.

Hamby K, Trexler A, Pearson TC, Larsen CP, Rigby MR, Kean LS.

Am J Transplant. 2007 Aug;7(8):1884-96.

PMID:
17617852
[PubMed - indexed for MEDLINE]
Free Article
3.

Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.

Raziuddin A, Longo DL, Mason L, Ortaldo JR, Bennett M, Murphy WJ.

J Immunol. 1998 Jan 1;160(1):87-94.

PMID:
9551959
[PubMed - indexed for MEDLINE]
Free Article
4.

Major histocompatibility complex-I expression on embryonic stem cell-derived vascular progenitor cells is critical for syngeneic transplant survival.

Ma M, Ding S, Lundqvist A, San H, Fang F, Konoplyannikov M, Berry C, Beltran LE, Chen G, Kovacic JC, Boehm M.

Stem Cells. 2010 Sep;28(9):1465-75. doi: 10.1002/stem.475.

PMID:
20629173
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Role of natural killer cell subsets in cardiac allograft rejection.

McNerney ME, Lee KM, Zhou P, Molinero L, Mashayekhi M, Guzior D, Sattar H, Kuppireddi S, Wang CR, Kumar V, Alegre ML.

Am J Transplant. 2006 Mar;6(3):505-13.

PMID:
16468959
[PubMed - indexed for MEDLINE]
Free Article
6.

Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing.

Sun K, Alvarez M, Ames E, Barao I, Chen M, Longo DL, Redelman D, Murphy WJ.

Blood. 2012 Feb 9;119(6):1590-8. doi: 10.1182/blood-2011-08-374314. Epub 2011 Dec 19.

PMID:
22184406
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Role of natural-killer group 2 member D ligands and intercellular adhesion molecule 1 in natural killer cell-mediated lysis of murine embryonic stem cells and embryonic stem cell-derived cardiomyocytes.

Frenzel LP, Abdullah Z, Kriegeskorte AK, Dieterich R, Lange N, Busch DH, Krönke M, Utermöhlen O, Hescheler J, Sarić T.

Stem Cells. 2009 Feb;27(2):307-16. doi: 10.1634/stemcells.2008-0528.

PMID:
18988711
[PubMed - indexed for MEDLINE]
Free Article
8.

Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts.

Raziuddin A, Bennett M, Winkler-Pickett R, Ortaldo JR, Longo DL, Murphy WJ.

Blood. 2000 Jun 15;95(12):3840-4.

PMID:
10845918
[PubMed - indexed for MEDLINE]
Free Article
9.

Natural killer cells in rejection and tolerance of solid organ allografts.

Benichou G, Yamada Y, Aoyama A, Madsen JC.

Curr Opin Organ Transplant. 2011 Feb;16(1):47-53. doi: 10.1097/MOT.0b013e32834254cf. Review.

PMID:
21157342
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium.

Swijnenburg RJ, Tanaka M, Vogel H, Baker J, Kofidis T, Gunawan F, Lebl DR, Caffarelli AD, de Bruin JL, Fedoseyeva EV, Robbins RC.

Circulation. 2005 Aug 30;112(9 Suppl):I166-72.

PMID:
16159810
[PubMed - indexed for MEDLINE]
Free Article
11.

Embryonic stem cells, derived either after in vitro fertilization or nuclear transfer, prolong survival of semiallogeneic heart transplants.

Imberti B, Casiraghi F, Cugini D, Azzollini N, Cassis P, Todeschini M, Solini S, Sebastiano V, Zuccotti M, Garagna S, Redi CA, Noris M, Morigi M, Remuzzi G.

J Immunol. 2011 Apr 1;186(7):4164-74. doi: 10.4049/jimmunol.1000654. Epub 2011 Mar 9.

PMID:
21389254
[PubMed - indexed for MEDLINE]
Free Article
12.

NK cells mediate costimulation blockade-resistant rejection of allogeneic stem cells during nonmyeloablative transplantation.

Kean LS, Hamby K, Koehn B, Lee E, Coley S, Stempora L, Adams AB, Heiss E, Pearson TC, Larsen CP.

Am J Transplant. 2006 Feb;6(2):292-304.

PMID:
16426313
[PubMed - indexed for MEDLINE]
Free Article
13.

The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.

Vallera DA, Taylor PA, Sprent J, Blazar BR.

Transplantation. 1994 Jan;57(2):249-56.

PMID:
7906058
[PubMed - indexed for MEDLINE]
14.

Pluripotent stem cells are highly susceptible targets for syngeneic, allogeneic, and xenogeneic natural killer cells.

Dressel R, Nolte J, Elsner L, Novota P, Guan K, Streckfuss-Bömeke K, Hasenfuss G, Jaenisch R, Engel W.

FASEB J. 2010 Jul;24(7):2164-77. doi: 10.1096/fj.09-134957. Epub 2010 Feb 9.

PMID:
20145206
[PubMed - indexed for MEDLINE]
Free Article
15.

Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.

Ohlén C, Höglund P, Sentman CL, Carbone E, Ljunggren HG, Koller B, Kärre K.

Eur J Immunol. 1995 May;25(5):1286-91.

PMID:
7774631
[PubMed - indexed for MEDLINE]
16.

NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.

van der Touw W, Burrell B, Lal G, Bromberg JS.

Transplantation. 2012 Sep 27;94(6):575-84.

PMID:
22914174
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells.

Lee LA, Sergio JJ, Sykes M.

Transplantation. 1996 Jan 15;61(1):125-32.

PMID:
8560550
[PubMed - indexed for MEDLINE]
18.

Natural killer cell-activating receptor NKG2D mediates innate immune targeting of allogeneic neural progenitor cell grafts.

Phillips LK, Gould EA, Babu H, Krams SM, Palmer TD, Martinez OM.

Stem Cells. 2013 Sep;31(9):1829-39. doi: 10.1002/stem.1422.

PMID:
23733329
[PubMed - indexed for MEDLINE]
19.

In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation.

Swijnenburg RJ, Schrepfer S, Cao F, Pearl JI, Xie X, Connolly AJ, Robbins RC, Wu JC.

Stem Cells Dev. 2008 Dec;17(6):1023-9. doi: 10.1089/scd.2008.0091.

PMID:
18491958
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens.

Raziuddin A, Longo DL, Bennett M, Winkler-Pickett R, Ortaldo JR, Murphy WJ.

Blood. 2002 Oct 15;100(8):3026-33.

PMID:
12351417
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk